Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

UPF-596 described as a novel glutamate antagonist

Aug. 23, 1996

Study of senile plaques guide Alzheimer's development

Aug. 23, 1996

Study indicates that estrogen may delay Alzheimer's disease onset

Aug. 23, 1996

Biogen signs Avonex distribution agreements

Aug. 23, 1996

Positive study results reported for CytoTherapeutics' encapsulated hCNTF device

Aug. 23, 1996

5-HT1D antagonists claimed by SmithKine Beecham

Aug. 23, 1996

Allelix describes dopamine D4 ligands for schizophrenia

Aug. 23, 1996

Zeneca files for U.K. marketing approval for Seroquel

Aug. 23, 1996

Allelix Biopharmaceuticals reports selective M1/M2 receptor ligands

Aug. 23, 1996

Draxis Health seeks Canadian approval of modafinil

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...